Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration

Philips and Imricor launched the first commercially available Interventional MR lab solution, combining Philips' 1.5T MRI platform with Imricor's MR-compatible systems and consumables. The solution enables MR-guided workflows for cardiac interventions like catheter ablation, offering radiation-free procedures with superior tissue visualization compared to X-ray fluoroscopy. It is commercially available immediately in CE-marked markets and in some U.S.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.